EFN

A new study conducted by Swedish researchers offers the possibility that combining treatment can cut the risk of dying for men suffering from prostate cancer in half. Men diagnosed with locally advanced prostate cancer where tested and found to have a 10% increased rate of survival by combining their hormone treatments with radiotherapy.

This discovery has promoted The Chicago Prostate Center who dedicates its time to diagnosing and treating men who diagnosed with prostate cancer, to present a new website. The site informs patients of treatment options, early treatment opportunities and many other areas of interest to individuals with prostate cancer and their families. Also, information concerning a brachytherapy treatment which is the implantation of a radioactive seed; a treatment specialized in by The Chicago Prostate Center.

Prostate Cancer is one of the most commonly diagnosed cancers among men living in the U.S. The combined treatment has been a standard practice in the U.S. for a number of years. Experts expect the same will be true in the future for treatment outside the USA. The selection of 900 men may make the difference in life among sufferers of prostate a specific type of prostate tumors.